Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.

Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP.

J Am Coll Cardiol. 2004 Jun 16;43(12):2293-9.

2.

Implantable cardioverter defibrillator for prevention of sudden cardiac death in patients with ventricular tachycardia and ventricular fibrillation: ICD therapy in sudden cardiac death.

Akhtar M, Jazayeri M, Sra J, Tchou P, Rovang K, Blanck Z, Dhala A, Deshpande S, Axtell K.

Pacing Clin Electrophysiol. 1993 Mar;16(3 Pt 2):511-8. Review.

PMID:
7681950
4.
5.

Screening and therapy for patients with nonsustained ventricular tachycardia.

Prystowsky EN.

Am J Cardiol. 2000 Nov 2;86(9A):34K-39K. Review.

PMID:
11084098
6.

Evidence rather than costs must guide use of the implantable cardioverter defibrillator.

Delacretaz E, Schlaepfer J, Metzger J, Fromer M, Kappenberger L.

Am J Cardiol. 2000 Nov 2;86(9A):52K-57K. Review.

PMID:
11084101
7.

The effect of coronary bypass graft surgery for the prevention of sudden cardiac death: recurrent episodes after ICD implantation and review of literature.

Autschbach R, Falk V, Gonska BD, Dalichau H.

Pacing Clin Electrophysiol. 1994 Mar;17(3 Pt 2):552-8. Review.

PMID:
7513886
8.

Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?

Ray IB, Reddy VY.

Int J Cardiol. 2005 Jan;98(1):15-20. Review.

PMID:
15676160
9.
11.

Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data.

Paul M, Gerss J, Schulze-Bahr E, Wichter T, Vahlhaus C, Wilde AA, Breithardt G, Eckardt L.

Eur Heart J. 2007 Sep;28(17):2126-33. Epub 2007 May 5. Review.

PMID:
17483540
12.

Non-pharmacological management of ventricular tachycardia.

Chinushi M, Aizawa Y.

Circ J. 2007;71 Suppl A:A97-105. Review.

13.

Sudden death in recipients of first-generation implantable cardioverter defibrillators: analysis of terminal events. Participating investigators.

Lehmann MH, Thomas A, Nabih M, Steinman RT, Fromm BS, Shah M, Norsted SW.

J Interv Cardiol. 1994 Oct;7(5):487-503. Review.

PMID:
10155197
14.
16.

An overview of the fifth-generation implantable cardioverter defibrillator.

Tanaka S.

Ann Thorac Cardiovasc Surg. 1998 Dec;4(6):303-11. Review.

PMID:
9914457
17.

Treatment approaches for patients with sustained VT/VF.

Mitchell LB, Roy D.

Can J Cardiol. 2000 Jun;16 Suppl C:23C-5C. Review. No abstract available.

PMID:
10887274
18.

[Myocardial ischemia and ventricular arrhythmia].

Vester EG.

Z Kardiol. 1998;87 Suppl 2:49-60. Review. German.

PMID:
9827462
19.
20.

What do implantable cardioverter/defibrillators teach us about the mechanisms of sudden cardiac death?

Grönefeld G, Hohnloser SH.

Cardiovasc Res. 2001 May;50(2):232-41. Review.

PMID:
11334827

Supplemental Content

Support Center